ON-TRK: prospective non-interventional study in patients with locally advanced or metastatic trk fusion cancer treated with larotrectinib
Principal investigator: Virve Pentikäinen
HUS Helsinki University Hospital, New Children´s Hospital
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
